ATE295542T1 - Testverfahren zum modulieren von nukleärer lokalisierung - Google Patents

Testverfahren zum modulieren von nukleärer lokalisierung

Info

Publication number
ATE295542T1
ATE295542T1 AT99940357T AT99940357T ATE295542T1 AT E295542 T1 ATE295542 T1 AT E295542T1 AT 99940357 T AT99940357 T AT 99940357T AT 99940357 T AT99940357 T AT 99940357T AT E295542 T1 ATE295542 T1 AT E295542T1
Authority
AT
Austria
Prior art keywords
cbp
test method
alpha
nuclear localization
importin alpha
Prior art date
Application number
AT99940357T
Other languages
English (en)
Inventor
Tony Kouzarides
Original Assignee
Chroma Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chroma Therapeutics Ltd filed Critical Chroma Therapeutics Ltd
Application granted granted Critical
Publication of ATE295542T1 publication Critical patent/ATE295542T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/91045Acyltransferases (2.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99940357T 1998-08-21 1999-08-20 Testverfahren zum modulieren von nukleärer lokalisierung ATE295542T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9818356.9A GB9818356D0 (en) 1998-08-21 1998-08-21 Assays,methods and means for modulating nuclear localisation
PCT/GB1999/002731 WO2000011478A1 (en) 1998-08-21 1999-08-20 Assays, methods and means for modulating nuclear localisation

Publications (1)

Publication Number Publication Date
ATE295542T1 true ATE295542T1 (de) 2005-05-15

Family

ID=10837687

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99940357T ATE295542T1 (de) 1998-08-21 1999-08-20 Testverfahren zum modulieren von nukleärer lokalisierung

Country Status (9)

Country Link
US (1) US6747005B1 (de)
EP (1) EP1105738B1 (de)
JP (1) JP2002523748A (de)
AT (1) ATE295542T1 (de)
AU (1) AU762690B2 (de)
CA (1) CA2338837A1 (de)
DE (1) DE69925281T2 (de)
GB (1) GB9818356D0 (de)
WO (1) WO2000011478A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080227752A1 (en) * 2004-06-30 2008-09-18 Trustees Of Boston University Methods to Inhibit Histone Acetyltransferase Using Glycosaminoglycans

Also Published As

Publication number Publication date
AU762690B2 (en) 2003-07-03
JP2002523748A (ja) 2002-07-30
CA2338837A1 (en) 2000-03-02
EP1105738B1 (de) 2005-05-11
GB9818356D0 (en) 1998-10-14
US6747005B1 (en) 2004-06-08
AU5435199A (en) 2000-03-14
DE69925281D1 (de) 2005-06-16
EP1105738A1 (de) 2001-06-13
DE69925281T2 (de) 2006-02-23
WO2000011478A1 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
DE3670509D1 (de) Anordnung zum test der empfindlichkeit von mikroorganismen.
DE69833505D1 (de) Bipolares elektrochirurgisches instrument zum verschliessen von gefässen
EA200200105A1 (ru) СОЕДИНЕНИЯ, МОДУЛИРУЮЩИЕ АКТИВНОСТЬ PPARγ;
TW351678B (en) Method for fractionating a solution to fractionate a solution
BR0315666A (pt) Dna de a34 e a33 do tipo 3, proteìnas, seus anticorpos e métodos de tratamento usando os mesmos
PT1017692E (pt) 4-heteroaril-tetrahidroquinolinas e sua aplicacao como inibidores da proteina de transferencia de ester de colesterol (ctep)
DE69822216D1 (de) Mehrteilige spritze zum manuellen auftragen von substanzen
DE58909461D1 (de) Verfahren zum Prüfen von Blattmaterial.
PT975359E (pt) Potencializacao da resposta imunitaria atraves de distribuicao de compostos que se ligam a uma dipeptidase citoplasmatica
DE69034061D1 (de) Methode der veränderung der expression von genen bei der transkription und zum nachweis von chemischen substanzen, die wie modulatoren der genexpression wirken
BR9810586A (pt) Peptìdio de aglutinação de integrin cìclico, composição farmacêutica que compreende o mesmo, processos para inibição e ensaio de aglutinação para identificar agentes de aglutinação de integrin
DE69434274D1 (de) Zusammensetzung zum regenerieren von gelenkknorpeln
DE68921504D1 (de) Behältnis zum Einschluss biologischer Stoffe.
DK0770876T3 (da) En screening-fremgangsmåde til at identificere ligander for målproteiner
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
ATE229972T1 (de) Schwefelsubstituierte peptide als inhibitoren für metalloproteinasen und der tnf-freisetzung
DE3650317D1 (de) Test zum nachweis von kampylobakter.
DE69603925D1 (de) System zum Anbringen von Etiketten
HUP0100668A2 (hu) Virulenciával kapcsolatos nukleinsavszekvenciák és alkalmazásuk
DE69902127D1 (de) Histon beinhaltende zusammenstellung zur behandlung von rheumatischer arthritis
TR199900561T2 (xx) G-protein i�levinin engellenmesi i�in ve �o�almaya y�nelik hastal�klar�n iyile�tirilmesi i�in yararl� trisiklik bile�ikler.
DE69727824D1 (de) Vorrichtung zum dichten Verbinden von Rohrleitungen
DE69925281D1 (de) Testverfahren zum modulieren von nukleärer lokalisierung
TR200101345T2 (tr) Hipoksiya'nın oluşturabildiği faktör 1alfa HIF-1alfa'nın değişik biçimleri için yöntemler.
DK0914605T3 (da) Molekylemodel for VLA-4-inhibitorer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties